Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
0.106
+0.003 (2.42%)
At close: Apr 28, 2026, 4:00 PM EDT
0.102
-0.005 (-4.25%)
After-hours: Apr 28, 2026, 7:50 PM EDT
Propanc Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Market Capitalization | 2 | 48 | 0 | 1 | 0 | - | |
| Market Cap Growth | - | 11514.72% | -25.62% | 26.73% | - | - | |
| Enterprise Value | 2 | 49 | 1 | 1 | 1 | - | |
| Last Close Price | 0.10 | 4.15 | 74.85 | 8083.83 | 220059.88 | 3095808.38 | |
| PB Ratio | 0.13 | 3.47 | -0.11 | -0.18 | -0.15 | - | |
| P/TBV Ratio | 0.21 | 3.47 | - | - | - | - | |
| Debt / Equity Ratio | 0.06 | 0.12 | -0.25 | -0.17 | -0.34 | -0.22 | |
| Net Debt / Equity Ratio | 0.01 | 0.12 | -0.24 | -0.17 | -0.34 | -0.22 | |
| Net Debt / EBITDA Ratio | 0.00 | -0.03 | -0.60 | -0.30 | -0.52 | -0.37 | |
| Net Debt / FCF Ratio | -0.03 | -4.23 | -0.99 | -0.48 | -0.72 | -0.59 | |
| Quick Ratio | 0.16 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | |
| Current Ratio | 2.13 | 1.50 | 0.01 | 0.01 | 0.01 | 0.00 | |
| Return on Equity (ROE) | -1811.69% | -1163.67% | - | - | - | - | |
| Return on Assets (ROA) | -535.73% | -363.36% | -1447.01% | -1564.19% | -2626.42% | -2029.40% | |
| Return on Capital Employed (ROCE) | -566.70% | -407.60% | 41.30% | 57.30% | 66.80% | 59.10% | |
| Earnings Yield | -3079.40% | -122.28% | -438.79% | -476.99% | -603.95% | - | |
| FCF Yield | -143.92% | -0.84% | -225.39% | -198.15% | -326.34% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.